CVS-2589

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameCVS-2589
Drug Alias NameCVS2589
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUrokinase plasminogen activator inhibitorsPlasminogen activators inhibitors
TargetsUrokinase plasminogen activatorPlasminogen activators
Therapy Area/IndicationsDiabetic RetinopathyNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDendreon San Diego Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDendreon San Diego Llc
Active IndicationsN/A
Inactive IndicationsDiabetic RetinopathyNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A